Market assessment of A Novel Capacitance Variation Measurement Mixed-Signal Integrated Circuit Based on High-Frequency Response

基于高频响应的新型电容变化测量混合信号集成电路的市场评估

• 批准号: 576584-2022
• 负责人: Mirhassani, MitraM
• 金额: $ 1.09万
• 依托单位: University of Windsor
• 依托单位国家: 加拿大
• 项目类别: Idea to Innovation
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-01-01 至 2023-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=751906
• 关键词: Market; assessment; Novel; Capacitance; Variation

The current outbreak of COVID-19 after recent infectious diseases such as SARS, MERS, Ebola, and different influenza variants has emerged that fast and accurate diagnosis is an important factor in the prevention of other global health and economic threats. A CMOS-based biosensor is a sensing structure that can detect the variations in the target biomarker's concentration and transform these variations into a meaningful electrical signal. CMOS-based biosensors have proven advantageous in terms of small size, low cost, high resolution, and high throughput. The developed technique can be used in health care facilities, such as walk-in clinics and hospitals. Additionally, since the proposed mechanism is fully autonomous, it's possible to use this readout mechanism for fast and accurate disease diagnosis for the public without requiring trained operators. Moreover, proper target recognition elements make it easily applicable in chemical detection applications for gas and other chemical detections in industrial environments.This proposal will be working on a market assessment to better understand how to bring this innovative technology to the market.

继SARS、MERS、埃博拉病毒和不同流感变种等近期传染病之后，当前的COVID-19爆发，快速、准确的诊断是预防其他全球健康和经济威胁的重要因素。 基于 CMOS 的生物传感器是一种传感结构，可以检测目标生物标志物浓度的变化，并将这些变化转化为有意义的电信号。基于 CMOS 的生物传感器已被证明在小尺寸、低成本、高分辨率和高通量方面具有优势。所开发的技术可用于医疗保健机构，例如步入式诊所和医院。此外，由于所提出的机制是完全自主的，因此可以使用这种读出机制为公众快速准确地诊断疾病，而无需经过培训的操作员。此外，适当的目标识别元件使其可以轻松应用于工业环境中气体和其他化学检测的化学检测应用。该提案将致力于市场评估，以更好地了解如何将这项创新技术推向市场。